4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-18-015882
EVP & Chief Financial Officer sold 8,532 shares at $18.72 ($159,712)
- EVP & Chief Financial Officer acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kelly James Patrick · EVP & Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-02-28 | Grant or award : show line 1 in the form | +40,000 | 208,066 | D | ||
| 2018-03-01 | Sale : show line 2 in the form | −8,532 | $18.72 | $159,712 | 199,534 | D |
| Open-market sales · 8,532 sh · avg $18.72 · $159,712 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-02-28 | Grant or award : show line 3 in the form Employee Stock Option (Right to Buy) | +80,000 | 80,000 | D |
Loading xslF345X03/doc4.xml…